New name reflects the Company’s strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature ...

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

Researchers from Children's Hospital of Philadelphia (CHOP) have developed a method to help cancer immunotherapies reach ...

Funding led by Mission BioCapital and Santé Ventures will accelerate AI-driven design and development of purpose-built miniprotein medicines across therapeutic applications The company today also ...

Cellular membrane proteins play important roles in cellular transport, signaling, and cell-to-cell communication. Malfunction in membrane proteins can lead to serious diseases, such as cancer. However ...

On September 11, 2025, the U.S. Food and Drug Administration (FDA) issued new guidance for the development of therapeutic protein biosimilars, focusing on comparative analytical assessment and quality ...

1 Department of Gastroenterology, The 3rd Affiliated Hospital (The First Hospital of Nanchang), Nanchang University, Nanchang, China 2 The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang ...

New computer simulations that model every atom of a protein as it folds into its final three-dimensional form support the existence of a recently identified type of protein misfolding. Proteins must ...

In terms of safety, among participants receiving monotherapy and combination therapy, 19 (27.9%) and 26 (35.6%) reported treatment-related adverse events (TRAEs) of Grade 3 or higher, respectively.